top of page

BMS and MD Anderson in lung cancer research collaboration

Bristol-Myers Squibb and The University of Texas MD Anderson Cancer Centre are to collaborate to evaluate innovative strategies for the potential use of Opdivo (nivolumab) and Yervoy(ipilimumab) to treat early- and advanced-stage lung cancer patients.


Click on this link for more information.

source: http://www.europeanpharmaceuticalreview.com/41545/news/industry-news/md-anderson-bms-lung-cancer/


#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page